The University of Chicago Header Logo

Connection

David Winchester to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications David Winchester has written about Receptor, ErbB-2.
David Winchester
Connection Strength
0.132
Receptor, ErbB-2
  1. Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
    View in: PubMed
    Score: 0.132
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.